|This message contains images. If you don't see images, click here to view.|
Advertise in this news brief.
Plan to join us for the "Best Week in Urology" in Maui on Oct. 26-31!
WSAUA Annual Meeting - Important Dates to Know
The 90th Annual Meeting – Oct. 26-31 at The Grand Wailea Hotel
Meeting Registration Now Open! Go Here
Looking for similar articles? Search here, keyword Urology.
Bladder Cancer Awareness Month
July is Bladder Cancer Awareness Month and the Clatterbridge Cancer Centre wants to raise awareness of the cancer which is seen by many as "one for the males." However, 25 percent of the cases do arise in women, and the Clatterbridge Cancer Centre wants to make women aware of the signs and symptoms to look for.
Global Urology Devices Market Estimated to Grow at CAGR of 6.37 Percent over 2013 to 2018
Research and Markets via News-Medical.Net
Urology devices are used for the diagnosis and treatment of disorders associated with male and female urinary tract systems and the male reproductive organs. Urology devices are used for the surgical management of medical conditions such as urinary tract infections, prostate enlargement bladder cancer, prostate cancer, kidney stones and urinary incontinence. The urology devices used currently are MI, so cause less pain, and enable a faster recovery and reduced hospital stay.
State Deemed $250M in Health Premium Increases Unreasonable
Reuters via California Healthline
About $250 million in planned health insurance premium increases in California during a 15-month period that ended in 2013 were excessive, according to a report released recently by Consumer Watchdog, Reuters reports. Consumer Watchdog is supporting a November ballot initiative that would give the state regulatory authority over health insurance rates.
Obamacare's next threat: A September surprise
Politico via HealthLeaders Media
Most state health insurance rates for 2015 are scheduled to be approved by early fall, and most are likely to rise, timing that couldn't be worse for Democrats already on defense in the midterms. The White House and its allies know they've been beaten in every previous round of Obamacare messaging, never more devastatingly than in 2010. And they know the results this November could hinge in large part on whether that happens again.
Robotic Surgery Offers Durable Prostate Cancer Control
Renal & Urology News
Robot-assisted radical prostatectomy confers affect 10-year control of localized prostate cancer, researchers reported online ahead of print in European Urology. Mireya Diaz, MD, of the Vattikuti Urology Institute at Henry Ford Hospital in Detroit, and colleagues studied 483 men with localized PCa who underwent RARP from 2001 to 2003. Of these, 108 experienced biochemical recurrence at a median follow-up of 121 months. The actuarial BCR-free, metastasis-free and cancer-specific survival rates at 10 years were 73.1 percent, 97.5 percent and 98.8 percent, respectively.
Studies Reveal Genes Key to RCC Development, Growth
Two recently published Mayo Clinic studies provide genetic clues to clear cell renal cell carcinoma that may have important therapeutic implications, researchers say.
In a genomic analysis of clear cell RCC, researchers uncovered 31 genes that they say are key to development, growth and spread of this most common form of kidney cancer. Eight of the genes had not been previously linked to kidney cancer, and six others were never known to be involved in any form of cancer.
Severe Erectile Dysfunction May Respond to Shockwave Therapy
Renal & Urology News
Low-intensity extracorporeal shockwave therapy may benefit men with severe erectile dysfunction, researchers reported online ahead of print in the International Journal of Urology.
OncoBriefs: High-Dose Myeloma Therapy, Prostate, Esophagus
A high-dose carfilzomib regimen for relapsed or refractory myeloma demonstrated durable activity and tolerability in a small, nonrandomized trial. A majority of 42 patients achieved at least partial response, with double the standard dose of carfilzomib, increased infusion duration and optional dexamethasone. The regimen proved active in subgroups of patients with bortezomib-refractory disease and unfavorable cytogenetics, as reported online in Blood.
CMS Releases 2015 Physician Fee Schedule Proposed Rule
The Centers for Medicare and Medicaid Services issued its 2015 Physician Fee Schedule proposed rule recently. The proposal rule includes changes to relative value units for calendar year 2015 and also adds procedures to the telehealth list, creates a process for added transparency in developing payment rates and issues provisions related to implementing separate payment for chronic care management services.
Digital Health Sees Record Cash Flow
Healthcare IT News
Record amounts of cash continue to pour into the digital health arena, with the mid year numbers seeing record highs for year-over-year growth, according to a new Rock Health report. The explosive growth in digital health funding, however, has some analysts uneasy over a potential bubble in the market.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063